Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF, 5411K) PPT slides of all figures Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Hirakawa, S. Articles by Detmar, M. Search for Related Content PubMed PubMed Citation Articles by Hirakawa, S. Articles by Detmar, M. Related Collections Related Article Social Bookmarking                      What's this?

¹ Cutaneous Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129
² Department of Immunobiology, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129
³ Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology Zurich, CH-8093 Zurich, Switzerland
⁴ Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215

CORRESPONDENCE Michael Detmar: michael.detmar{at}pharma.ethz.ch

The mechanisms of tumor metastasis to the sentinel lymph nodes are poorly understood. Vascular endothelial growth factor (VEGF)-A plays a principle role in tumor progression and angiogenesis; however, its role in tumor-associated lymphangiogenesis and lymphatic metastasis has remained unclear. We created transgenic mice that overexpress VEGF-A and green fluorescent protein specifically in the skin, and subjected them to a standard chemically-induced skin carcinogenesis regimen. We found that VEGF-A not only strongly promotes multistep skin carcinogenesis, but also induces active proliferation of VEGF receptor-2–expressing tumor-associated lymphatic vessels as well as tumor metastasis to the sentinel and distant lymph nodes. The lymphangiogenic activity of VEGF-A–expressing tumor cells was maintained within metastasis-containing lymph nodes. The most surprising finding of our study was that even before metastasizing, VEGF-A–overexpressing primary tumors induced sentinel lymph node lymphangiogenesis. This suggests that primary tumors might begin preparing their future metastatic site by producing lymphangiogenic factors that mediate their efficient transport to sentinel lymph nodes. This newly identified mechanism of inducing lymph node lymphangiogenesis likely contributes to tumor metastasis, and therefore, represents a new therapeutic target for advanced cancer and/or for the prevention of metastasis.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Related Article

Paving the way to metastasis

Heather L. Van Epps
J. Exp. Med. 2005 201: 1022-1023. [Full Text] [PDF]

This article has been cited by other articles:

• Schicher, N., Paulitschke, V., Swoboda, A., Kunstfeld, R., Loewe, R., Pilarski, P., Pehamberger, H., Hoeller, C. (2009). Erlotinib and Bevacizumab Have Synergistic Activity against Melanoma. Clin. Cancer Res. 15: 3495-3502 [Abstract] [Full Text]  
• Lahat, G., Lazar, A., Wang, X., Wang, W.-L., Zhu, Q.-S., Hunt, K. K., Pollock, R. E., Lev, D. (2009). Increased Vascular Endothelial Growth Factor-C Expression Is Insufficient to Induce Lymphatic Metastasis in Human Soft-Tissue Sarcomas. Clin. Cancer Res. 15: 2637-2646 [Abstract] [Full Text]  
• Ruiz de Almodovar, C., Lambrechts, D., Mazzone, M., Carmeliet, P. (2009). Role and Therapeutic Potential of VEGF in the Nervous System. Physiol. Rev. 89: 607-648 [Abstract] [Full Text]  
• Kang, S., Lee, S.-P., Kim, K. E., Kim, H.-Z., Memet, S., Koh, G. Y. (2009). Toll-like receptor 4 in lymphatic endothelial cells contributes to LPS-induced lymphangiogenesis by chemotactic recruitment of macrophages. Blood 113: 2605-2613 [Abstract] [Full Text]  
• Brunet-Dunand, S. E., Vouyovitch, C., Araneda, S., Pandey, V., Vidal, L. J.-P., Print, C., Mertani, H. C., Lobie, P. E., Perry, J. K. (2009). Autocrine Human Growth Hormone Promotes Tumor Angiogenesis in Mammary Carcinoma. Endocrinology 150: 1341-1352 [Abstract] [Full Text]  
• Nguyen Huu, S., Oster, M., Avril, M.-F., Boitier, F., Mortier, L., Richard, M.-A., Kerob, D., Maubec, E., Souteyrand, P., Moguelet, P., Khosrotehrani, K., Aractingi, S. (2009). Fetal Microchimeric Cells Participate in Tumour Angiogenesis in Melanomas Occurring during Pregnancy. Am. J. Pathol. 174: 630-637 [Abstract] [Full Text]  
• Boonkitticharoen, V., Kulapaditharom, B., Leopairut, J., Kraiphibul, P., Larbcharoensub, N., Cheewaruangroj, W., Chintrakarn, C., Pochanukul, L. (2008). Vascular Endothelial Growth Factor A and Proliferation Marker in Prediction of Lymph Node Metastasis in Oral and Pharyngeal Squamous Cell Carcinoma. Arch Otolaryngol Head Neck Surg 134: 1305-1311 [Abstract] [Full Text]  
• Burton, J. B., Priceman, S. J., Sung, J. L., Brakenhielm, E., An, D. S., Pytowski, B., Alitalo, K., Wu, L. (2008). Suppression of Prostate Cancer Nodal and Systemic Metastasis by Blockade of the Lymphangiogenic Axis. Cancer Res. 68: 7828-7837 [Abstract] [Full Text]  
• Chyou, S., Ekland, E. H., Carpenter, A. C., Tzeng, T.-C. J., Tian, S., Michaud, M., Madri, J. A., Lu, T. T. (2008). Fibroblast-Type Reticular Stromal Cells Regulate the Lymph Node Vasculature. J. Immunol. 181: 3887-3896 [Abstract] [Full Text]  
• Shin, J. W., Huggenberger, R., Detmar, M. (2008). Transcriptional profiling of VEGF-A and VEGF-C target genes in lymphatic endothelium reveals endothelial-specific molecule-1 as a novel mediator of lymphangiogenesis. Blood 112: 2318-2326 [Abstract] [Full Text]  
• Banziger-Tobler, N. E., Halin, C., Kajiya, K., Detmar, M. (2008). Growth Hormone Promotes Lymphangiogenesis. Am. J. Pathol. 173: 586-597 [Abstract] [Full Text]  
• Halin, C., Fahrngruber, H., Meingassner, J. G., Bold, G., Littlewood-Evans, A., Stuetz, A., Detmar, M. (2008). Inhibition of Chronic and Acute Skin Inflammation by Treatment with a Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor. Am. J. Pathol. 173: 265-277 [Abstract] [Full Text]  
• Roesli, C., Mumprecht, V., Neri, D., Detmar, M. (2008). Identification of the surface-accessible, lineage-specific vascular proteome by two-dimensional peptide mapping. FASEB J. 22: 1933-1944 [Abstract] [Full Text]  
• Van den Eynden, G. G., Smid, M., Van Laere, S. J., Colpaert, C. G., Van der Auwera, I., Bich, T. X., van Dam, P., den Bakker, M. A., Dirix, L. Y., Van Marck, E. A., Vermeulen, P. B., Foekens, J. A. (2008). Gene Expression Profiles Associated with the Presence of a Fibrotic Focus and the Growth Pattern in Lymph Node-Negative Breast Cancer. Clin. Cancer Res. 14: 2944-2952 [Abstract] [Full Text]  
• Murakami, M., Zheng, Y., Hirashima, M., Suda, T., Morita, Y., Ooehara, J., Ema, H., Fong, G.-H., Shibuya, M. (2008). VEGFR1 Tyrosine Kinase Signaling Promotes Lymphangiogenesis as Well as Angiogenesis Indirectly via Macrophage Recruitment. Arterioscler. Thromb. Vasc. Bio. 28: 658-664 [Abstract] [Full Text]  
• Thelen, A., Scholz, A., Benckert, C., Weichert, W., Dietz, E., Wiedenmann, B., Neuhaus, P., Jonas, S. (2008). Tumor-Associated Lymphangiogenesis Correlates with Lymph Node Metastases and Prognosis in Hilar Cholangiocarcinoma. Ann. Surg. Oncol. 15: 791-799 [Abstract] [Full Text]  
• Sini, P., Samarzija, I., Baffert, F., Littlewood-Evans, A., Schnell, C., Theuer, A., Christian, S., Boos, A., Hess-Stumpp, H., Foekens, J. A., Setyono-Han, B., Wood, J., Hynes, N. E. (2008). Inhibition of Multiple Vascular Endothelial Growth Factor Receptors (VEGFR) Blocks Lymph Node Metastases but Inhibition of VEGFR-2 Is Sufficient to Sensitize Tumor Cells to Platinum-Based Chemotherapeutics. Cancer Res. 68: 1581-1592 [Abstract] [Full Text]  
• Wels, J., Kaplan, R. N., Rafii, S., Lyden, D. (2008). Migratory neighbors and distant invaders: tumor-associated niche cells. Genes Dev. 22: 559-574 [Abstract] [Full Text]  
• Yu, L., Wu, X., Cheng, Z., Lee, C. V., LeCouter, J., Campa, C., Fuh, G., Lowman, H., Ferrara, N. (2008). Interaction between Bevacizumab and Murine VEGF-A: A Reassessment. IOVS 49: 522-527 [Abstract] [Full Text]  
• Ovchinnikov, D. A., van Zuylen, W. J. M., DeBats, C. E. E., Alexander, K. A., Kellie, S., Hume, D. A. (2008). Expression of Gal4-dependent transgenes in cells of the mononuclear phagocyte system labeled with enhanced cyan fluorescent protein using Csf1r-Gal4VP16/UAS-ECFP double-transgenic mice. J. Leukoc. Biol. 83: 430-433 [Abstract] [Full Text]  
• Bachmann, B. O., Bock, F., Wiegand, S. J., Maruyama, K., Dana, M. R., Kruse, F. E., Luetjen-Drecoll, E., Cursiefen, C. (2008). Promotion of Graft Survival by Vascular Endothelial Growth Factor A Neutralization After High-Risk Corneal Transplantation. Arch Ophthalmol 126: 71-77 [Abstract] [Full Text]  
• Riquet, M., Bagan, P., Le Pimpec Barthes, F., Banu, E., Scotte, F., Foucault, C., Dujon, A., Danel, C. (2007). Completely Resected Non-Small Cell Lung Cancer: Reconsidering Prognostic Value and Significance of N2 Metastases. Ann. Thorac. Surg. 84: 1818-1824 [Abstract] [Full Text]  
• Halin, C., Tobler, N. E., Vigl, B., Brown, L. F., Detmar, M. (2007). VEGF-A produced by chronically inflamed tissue induces lymphangiogenesis in draining lymph nodes. Blood 110: 3158-3167 [Abstract] [Full Text]  
• Sundar, S. S., Ganesan, T. S. (2007). Role of Lymphangiogenesis in Cancer. JCO 25: 4298-4307 [Abstract] [Full Text]  
• Van den Eynden, G. G., Vandenberghe, M. K., van Dam, P.-J. H., Colpaert, C. G., van Dam, P., Dirix, L. Y., Vermeulen, P. B., Van Marck, E. A. (2007). Increased Sentinel Lymph Node Lymphangiogenesis is Associated with Nonsentinel Axillary Lymph Node Involvement in Breast Cancer Patients with a Positive Sentinel Node. Clin. Cancer Res. 13: 5391-5397 [Abstract] [Full Text]  
• Dietrich, T., Onderka, J., Bock, F., Kruse, F. E., Vossmeyer, D., Stragies, R., Zahn, G., Cursiefen, C. (2007). Inhibition of Inflammatory Lymphangiogenesis by Integrin {alpha}5 Blockade. Am. J. Pathol. 171: 361-372 [Abstract] [Full Text]  
• Wirzenius, M., Tammela, T., Uutela, M., He, Y., Odorisio, T., Zambruno, G., Nagy, J. A., Dvorak, H. F., Yla-Herttuala, S., Shibuya, M., Alitalo, K. (2007). Distinct vascular endothelial growth factor signals for lymphatic vessel enlargement and sprouting. JEM 204: 1431-1440 [Abstract] [Full Text]  
• Eichten, A., Hyun, W. C., Coussens, L. M. (2007). Distinctive Features of Angiogenesis and Lymphangiogenesis Determine Their Functionality during De novo Tumor Development. Cancer Res. 67: 5211-5220 [Abstract] [Full Text]  
• Jain, R. K., Tong, R. T., Munn, L. L. (2007). Effect of Vascular Normalization by Antiangiogenic Therapy on Interstitial Hypertension, Peritumor Edema, and Lymphatic Metastasis: Insights from a Mathematical Model. Cancer Res. 67: 2729-2735 [Abstract] [Full Text]  
• Rad, F. H., Le Buanec, H., Paturance, S., Larcier, P., Genne, P., Ryffel, B., Bensussan, A., Bizzini, B., Gallo, R. C., Zagury, D., Uzan, G. (2007). VEGF kinoid vaccine, a therapeutic approach against tumor angiogenesis and metastases. Proc. Natl. Acad. Sci. USA 104: 2837-2842 [Abstract] [Full Text]  
• Harrell, M. I., Iritani, B. M., Ruddell, A. (2007). Tumor-Induced Sentinel Lymph Node Lymphangiogenesis and Increased Lymph Flow Precede Melanoma Metastasis. Am. J. Pathol. 170: 774-786 [Abstract] [Full Text]  
• Hirakawa, S., Brown, L. F., Kodama, S., Paavonen, K., Alitalo, K., Detmar, M. (2007). VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Blood 109: 1010-1017 [Abstract] [Full Text]  
• Azzali, G. (2007). Tumor Cell Transendothelial Passage in the Absorbing Lymphatic Vessel of Transgenic Adenocarcinoma Mouse Prostate. Am. J. Pathol. 170: 334-346 [Abstract] [Full Text]  
• Wissmann, C., Detmar, M. (2006). Pathways Targeting Tumor Lymphangiogenesis. Clin. Cancer Res. 12: 6865-6868 [Abstract] [Full Text]  
• Qian, C.-N., Berghuis, B., Tsarfaty, G., Bruch, M., Kort, E. J., Ditlev, J., Tsarfaty, I., Hudson, E., Jackson, D. G., Petillo, D., Chen, J., Resau, J. H., Teh, B. T. (2006). Preparing the "Soil": The Primary Tumor Induces Vasculature Reorganization in the Sentinel Lymph Node before the Arrival of Metastatic Cancer Cells. Cancer Res. 66: 10365-10376 [Abstract] [Full Text]  
• Zeng, Y., Opeskin, K., Goad, J., Williams, E. D. (2006). Tumor-Induced Activation of Lymphatic Endothelial Cells via Vascular Endothelial Growth Factor Receptor-2 Is Critical for Prostate Cancer Lymphatic Metastasis. Cancer Res. 66: 9566-9575 [Abstract] [Full Text]  
• Tobler, N. E., Detmar, M. (2006). Tumor and lymph node lymphangiogenesis--impact on cancer metastasis. J. Leukoc. Biol. 80: 691-696 [Abstract] [Full Text]  
• Kajiya, K., Hirakawa, S., Detmar, M. (2006). Vascular Endothelial Growth Factor-A Mediates Ultraviolet B-Induced Impairment of Lymphatic Vessel Function. Am. J. Pathol. 169: 1496-1503 [Abstract] [Full Text]  
• Demicheli, R., Biganzoli, E., Boracchi, P., Greco, M., Hrushesky, W. J.M., Retsky, M. W. (2006). Allometric Scaling Law Questions the Traditional Mechanical Model for Axillary Lymph Node Involvement in Breast Cancer. JCO 24: 4391-4396 [Abstract] [Full Text]  
• Shayan, R., Achen, M. G., Stacker, S. A. (2006). Lymphatic vessels in cancer metastasis: bridging the gaps. Carcinogenesis 27: 1729-1738 [Abstract] [Full Text]  
• Hoshida, T., Isaka, N., Hagendoorn, J., di Tomaso, E., Chen, Y.-L., Pytowski, B., Fukumura, D., Padera, T. P., Jain, R. K. (2006). Imaging Steps of Lymphatic Metastasis Reveals That Vascular Endothelial Growth Factor-C Increases Metastasis by Increasing Delivery of Cancer Cells to Lymph Nodes: Therapeutic Implications. Cancer Res. 66: 8065-8075 [Abstract] [Full Text]  
• Webster, B., Ekland, E. H., Agle, L. M., Chyou, S., Ruggieri, R., Lu, T. T. (2006). Regulation of lymph node vascular growth by dendritic cells. JEM 203: 1903-1913 [Abstract] [Full Text]  
• Cao, R., Bjorndahl, M. A., Gallego, M. I., Chen, S., Religa, P., Hansen, A. J., Cao, Y. (2006). Hepatocyte growth factor is a lymphangiogenic factor with an indirect mechanism of action. Blood 107: 3531-3536 [Abstract] [Full Text]  
• Miyata, Y., Kanda, S., Ohba, K., Nomata, K., Hayashida, Y., Eguchi, J., Hayashi, T., Kanetake, H. (2006). Lymphangiogenesis and Angiogenesis in Bladder Cancer: Prognostic Implications and Regulation by Vascular Endothelial Growth Factors-A, -C, and -D. Clin. Cancer Res. 12: 800-806 [Abstract] [Full Text]  
• Liersch, R., Nay, F., Lu, L., Detmar, M. (2006). Induction of lymphatic endothelial cell differentiation in embryoid bodies. Blood 107: 1214-1216 [Abstract] [Full Text]  
• Religa, P., Cao, R., Bjorndahl, M., Zhou, Z., Zhu, Z., Cao, Y. (2005). Presence of bone marrow-derived circulating progenitor endothelial cells in the newly formed lymphatic vessels. Blood 106: 4184-4190 [Abstract] [Full Text]  
• Bjorndahl, M., Cao, R., Nissen, L. J., Clasper, S., Johnson, L. A., Xue, Y., Zhou, Z., Jackson, D., Jon Hansen, A., Cao, Y. (2005). Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo. Proc. Natl. Acad. Sci. USA 102: 15593-15598 [Abstract] [Full Text]  
• Bjorndahl, M. A., Cao, R., Burton, J. B., Brakenhielm, E., Religa, P., Galter, D., Wu, L., Cao, Y. (2005). Vascular Endothelial Growth Factor-A Promotes Peritumoral Lymphangiogenesis and Lymphatic Metastasis. Cancer Res. 65: 9261-9268 [Abstract] [Full Text]  
• Lin, J., Lalani, A. S., Harding, T. C., Gonzalez, M., Wu, W.-W., Luan, B., Tu, G. H., Koprivnikar, K., VanRoey, M. J., He, Y., Alitalo, K., Jooss, K. (2005). Inhibition of Lymphogenous Metastasis Using Adeno-Associated Virus-Mediated Gene Transfer of a Soluble VEGFR-3 Decoy Receptor. Cancer Res. 65: 6901-6909 [Abstract] [Full Text]  
• Augustin, H. G. (2005). Angiopoietins meet lymphatics. Blood 105: 4541-4542 [Full Text]  
• Hirakawa, S., Kodama, S., Kunstfeld, R., Kajiya, K., Brown, L. F., Detmar, M. (2005). VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. JCB 169: i1-i1 [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS